Dublin Core
Title
Fungal Infections Complicating COVID-19
Subject
EMERGING INFECTIOUS DISEASES--EPIDEMIOLOGY
Description
oronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections, a significant proportion of cases progress to severe pneumonia and acute respiratory distress syndrome requiring critical care. Opportunistic infections following severe respiratory viral infections have been recognized since the 1918 influenza pandemic. Among critically ill patients with COVID-19, secondary fungal infections caused by Aspergillus and Candida spp. are increasingly described, affecting up to 30% of COVID-19 patients requiring intensive care treatment. This collection of manuscripts focuses on fungal infections complicating COVID-19, including immunological mechanisms and pathogenesis, diagnosis, and treatment.
Creator
Hoenigl, Martin (editor)
Talento, Alida Fe (editor)
Talento, Alida Fe (editor)
Source
https://directory.doabooks.org/handle/20.500.12854/76280
Publisher
MDPI - Multidisciplinary Digital Publishing Institute
Date
2021
Contributor
Sulistiorini
Rights
https://creativecommons.org/licenses/by/4.0/
Relation
1. Alida Fe Talento and Martin Hoenigl
Fungal Infections Complicating COVID-19: With the Rain Comes the Spores
2. Amir Arastehfar, Agostinho Carvalho, Frank L. van de Veerdonk, Jeffrey D. Jenks,
Philipp Koehler, Robert Krause, Oliver A. Cornely, David S. Perlin, Cornelia Lass-Fl¨orl
and Martin Hoenigl
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
3. Jean-Pierre Gangneux, Florian Reizine, H´el`ene Guegan, Kieran Pinceaux, Pierre Le Balch,
Emilie Prat, Romain Pelletier, Sorya Belaz, Mathieu Le Souhaitier, Yves Le Tulzo,
Philippe Seguin, Mathieu Lederlin, Jean-Marc Tadi´e and Florence Robert-Gangneux
Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to
Categorize Aspergillosis in ICU Patients? A Monocentric Experience
4. Aia Mohamed, Thomas R. Rogers and Alida Fe Talento
COVID-19 Associated Invasive Pulmonary Aspergillosis:
Therapeutic Challenges
5. Eelco F. J. Meijer, Anton S. M. Dofferhoff, Oscar Hoiting, Jochem B. Buil and Jacques F. Meis
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host:
A Case Report
Fungal Infections Complicating COVID-19: With the Rain Comes the Spores
2. Amir Arastehfar, Agostinho Carvalho, Frank L. van de Veerdonk, Jeffrey D. Jenks,
Philipp Koehler, Robert Krause, Oliver A. Cornely, David S. Perlin, Cornelia Lass-Fl¨orl
and Martin Hoenigl
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
3. Jean-Pierre Gangneux, Florian Reizine, H´el`ene Guegan, Kieran Pinceaux, Pierre Le Balch,
Emilie Prat, Romain Pelletier, Sorya Belaz, Mathieu Le Souhaitier, Yves Le Tulzo,
Philippe Seguin, Mathieu Lederlin, Jean-Marc Tadi´e and Florence Robert-Gangneux
Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to
Categorize Aspergillosis in ICU Patients? A Monocentric Experience
4. Aia Mohamed, Thomas R. Rogers and Alida Fe Talento
COVID-19 Associated Invasive Pulmonary Aspergillosis:
Therapeutic Challenges
5. Eelco F. J. Meijer, Anton S. M. Dofferhoff, Oscar Hoiting, Jochem B. Buil and Jacques F. Meis
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host:
A Case Report
Format
Pdf
Language
English
Type
Textbooks
Identifier
DOI
10.3390/books978-3-0365-0555-8
10.3390/books978-3-0365-0555-8